Pharmaniaga Berhad (7081.KL)
MYR 0.36
(0.0%)
MYR 0.36
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 46.95 Million | -142.33 Million | -64.05 Million | -25.71 Million | 189.76 Million |
| Net Income | -80.16 Million | -629.92 Million | 172.15 Million | 27.48 Million | -149.21 Million |
| Depreciation & Amortization | 38.77 Million | 34.02 Million | 31.7 Million | 30.76 Million | 34.74 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | 2.09 Million | 1.73 Million | 951 Thousand | 2.99 Million |
| Change in working capital | - | - | - | - | - |
| Other non-cash items | 88.34 Million | 451.47 Million | -269.64 Million | -84.91 Million | 301.24 Million |
| Investing Cash Flow | -67.93 Million | -72.33 Million | -45.55 Million | -32.63 Million | -72.68 Million |
| Investments in PPE | -73.66 Million | -77.63 Million | -45.35 Million | -32.63 Million | -20.37 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | -413 Thousand | - | -5000.00 |
| Sales/Maturities of investments | - | 5.24 Million | - | - | - |
| Other Investing Activities | -17.26 Million | -13.07 Million | -15.17 Million | -23.38 Million | -52.3 Million |
| Financing Cash Flow | 95.26 Million | 220.79 Million | 120.73 Million | 71.48 Million | -125.27 Million |
| Debt repayment | -19.52 Million | -310.97 Million | -182.6 Million | -108.77 Million | -3.82 Million |
| Dividends payments | -7.85 Million | -82.52 Million | -58.94 Million | -26.14 Million | -40.39 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 45.85 Million | - | - | - | - |
| Other Financing Activities | 50 Million | -99 Thousand | -44 Thousand | -86 Thousand | -81.05 Million |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | - | - | - | - | - |
| Cash at beginning of period | 52.84 Million | 47.11 Million | 35.86 Million | 22.95 Million | 30.82 Million |
| Cash at end of period | 127.44 Million | 52.84 Million | 47.11 Million | 35.86 Million | 22.95 Million |
| Capital Expenditure | -73.66 Million | -77.63 Million | -45.35 Million | -32.63 Million | -20.37 Million |
| Effect of forex changes on cash | 307 Thousand | -386 Thousand | 125 Thousand | -231 Thousand | 318 Thousand |
| Net cash flow / Change in cash | 74.59 Million | 5.73 Million | 11.25 Million | 12.91 Million | -7.87 Million |
| Free Cash Flow | -26.71 Million | -219.97 Million | -109.41 Million | -58.34 Million | 169.38 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.79 Million | 25.64 Million | -35.42 Million | -80.16 Million | -49.33 Million | 1.96 Million |
| Depreciation & Amortization | 10.28 Million | 9.29 Million | 12.77 Million | 38.77 Million | 8.68 Million | 8.5 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | -21.41 Million | -90.33 Million | 54.03 Million | 88.34 Million | 13.09 Million | 98.3 Million |
| Investing Cash Flow | -9.35 Million | -15.1 Million | -37.58 Million | -67.93 Million | -17.43 Million | -8.25 Million |
| Investments in PPE | -9.4 Million | -8.57 Million | -38.27 Million | -73.66 Million | -17.64 Million | -12.79 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | 40 Thousand | -6.53 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -3.41 Million | -7.83 Million | -14.82 Million | -17.26 Million | -2.49 Million | 1.85 Million |
| Financing Cash Flow | -1.99 Million | 23.35 Million | 103.05 Million | 95.26 Million | 48.29 Million | -129.94 Million |
| Debt repayment | -143 Thousand | -24.84 Million | -57.81 Million | -19.52 Million | -4.8 Million | -127.22 Million |
| Dividends payments | - | - | - | -7.85 Million | -30 Thousand | -30 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 45.85 Million | - | - |
| Other Financing Activities | -195 Thousand | - | 3.29 Billion | 50 Million | 45.85 Million | -84.34 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 80.06 Million | 127.44 Million | 30.72 Million | 52.84 Million | 27.77 Million | 56.62 Million |
| Cash at end of period | 60.26 Million | 80.06 Million | 127.44 Million | 127.44 Million | 30.72 Million | 27.77 Million |
| Capital Expenditure | -9.4 Million | -8.57 Million | -38.27 Million | -73.66 Million | -17.64 Million | -12.79 Million |
| Effect of forex changes on cash | -119 Thousand | -229 Thousand | -128 Thousand | 307 Thousand | -358 Thousand | 579 Thousand |
| Net cash flow / Change in cash | -19.79 Million | -47.37 Million | 96.71 Million | 74.59 Million | 2.95 Million | -28.84 Million |
| Free Cash Flow | -17.73 Million | -63.96 Million | -6.9 Million | -26.71 Million | -45.2 Million | 95.97 Million |
BFLY
000997
HPI
SKWG
OTGLY
PE&OLES